Metabolism genes
Variants in alcohol- and nicotine-metabolism genes can affect how quickly a substance is processed. That context can help frame a clinical conversation.
Gene Recovery Science
Genetic context for recovery conversations
Gene Recovery summarises peer-reviewed addiction-genomics and pharmacogenomics findings in plain language, so genetic context can support a better-informed clinical conversation.
Pharmacogenomics
Medication response can vary by genotype. Gene Recovery treats pharmacogenomic context as a discussion aid for clinicians, not as a prescribing engine.
Risk context
Addiction risk is shaped by biology, environment, history, and support. A variant is never destiny, and a report is never a diagnosis.
What a report can and cannot say
Gene Recovery reports are designed to explain studied genetic markers, uncertainty, and clinical limits. They do not predict a person's future, diagnose addiction, or replace care from a recovery professional.
- ADH1B and ALDH2 alcohol-metabolism context
- CHRNA5 and CHRNA3 nicotine-response literature
- OPRM1 opioid-response literature
- Pharmacogenomic markers relevant to medication discussion